Peter Petitt, Managing Director at Aon, and Foley & Lardner lawyers Lisa Conmy and Alidad Vakili engaged in an informative panel discussion on venture debt moderated by Bret Waters at 4thly Accelerator as part of the livestream for startup founders series hosted by 4thly and Foley.
The program covered when entrepreneurs can leverage debt from banks or non-bank lenders, how venture debt is structured, and the considerations.
The key takeaways were:
- Venture Debt comes in at the same time as or follows venture equity – best time to raise it is immediately after you raise equity, you have 12-18 months of runway and you can show recurring revenue streams.
- A company needs to have enough collateral, or something that can be used as collateral, such as intellectual property (IP), to consider a debt financing.
- Recurring revenue and IP are common sources of collateral in venture debt deals. Aon looks at IP – the world’s largest uninsured asset class and the world’s most undervalued asset class. A company’s IP portfolio is often its most valuable asset.
- We see companies securing a facility when times are good to enable them to extend runway before the next equity financing so that companies can raise in optimal conditions, and at a higher valuation than they would otherwise.
- It’s important to understand the covenants that are being requested and be careful of which ones align with the trajectory of the company.
- Warrants are a frequently requested sweetener in venture debt deals and are typically exercisable for common stock at a penny exercise price. Be careful of a penny exercise price if the warrants are exercisable for preferred stock.
People
Related Insights
March 12, 2026
Foley Viewpoints
What To Do If You Receive a NAIC AI Systems Evaluation Tool Pilot Request
Summary & Takeaways: The NAIC’s AI Systems Evaluation Tool Pilot Project has begun generating domiciliary regulator requests for…
March 12, 2026
Health Care Law Today
GLP‑1 Compliance: FDA Targets Telehealth Marketing in 30 New Warning Letters
On March 3, 2026, U.S. Food & Drug Administration (FDA) sent 30 warning letters to telehealth companies that market compounded GLP‑1…
March 11, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About…Managing the Aftermath of the Supreme Court’s IEEPA Tariff Decision (Part III)
The importer of record is the entity that initially pays all tariffs and thus is the entity that would receive any IEEPA tariff refunds. Nonetheless, behind the scenes there often are a variety of mechanisms importers of record may have used to handle the often unexpected tariffs, including pushing back on suppliers for price concessions, using surcharges to pass along tariffs, or generally increasing price. In many cases, other parties may be looking to share any potential refunds.